Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06425445Not ApplicableCompleted

Quantitative Assessment of Orofacial Muscle Function in FSHD

Role: lead

NCT06435793Not ApplicableCompleted

Expiratory Pressure in Healthy Individuals

Role: collaborator

NCT06149468Recruiting

CAP48 - Autism in Children and Adolescents

Role: collaborator

NCT06666101Not ApplicableNot Yet Recruiting

Effects of n3 LC PUFAs on Inflammatory, Immune and Senescence Features in Polyvascular Older Subjects (OMSAGE)

Role: collaborator

NCT05284669Not ApplicableCompleted

Effect of an E-learning Intervention on Knowledge, Attitudes and Beliefs of Healthcare Professionals Managing Low Back Pain.

Role: collaborator

NCT05019443Not ApplicableUnknown

WEDGES: Coronary Lesion Preparation With Enhanced Dilatation for Good Expansion of Stent: Assessment of a New Scoring Balloon by Quantitative Stent Enhanced Visualization

Role: collaborator

All 6 trials loaded